3D Printing Group

Created by Abe Gladstone on 15 February, 2018

3D printed drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.

3D printing offers the possibility of creating a personalized medicine system through automated control over drug dose and is suitable for both low and high drug concentrations. These advantages allow drug companies to not only boost efficacy and adherence, but also contribute to their brand longevity by expanding and capturing market share with other dosage forms.

For instance, FabRx Ltd. completed the world’s first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines in April 2020.

Leading companies operating in the 3D printed drugs are Aprecia Pharmaceuticals, LLC, FabRx Ltd, Cycle Pharmaceuticals, GlaxoSmithKline PLC., Astrazeneca, Tvasta, and Merck KGGA

To know more details get free PDF Brochure https://bit.ly/3qWodss